Variant report
Variant | nsv819662 |
---|---|
Chromosome Location | chr8:50115746-50122871 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:50114787..50117721-chr8:50120524..50123676,3 | K562 | blood: | |
2 | chr8:50122009..50123670-chr8:50128301..50129864,2 | K562 | blood: | |
3 | chr8:50114787..50117721-chr8:50120524..50123676,3 | K562 | blood: | |
4 | chr8:50104222..50107867-chr8:50114217..50118175,4 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C8orf22-2 | chr8:50118940-50119026 | NONHSAT126506 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543598627 | chr8:50118217-50118218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562041458 | chr8:50118238-50118239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560764170 | chr8:50118254-50118255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548467097 | chr8:50118256-50118257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35897910 | chr8:50118274-50118275 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs527445192 | chr8:50118277-50118278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35347194 | chr8:50118306-50118307 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs35435104 | chr8:50118367-50118368 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs568597300 | chr8:50118372-50118373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs115897748 | chr8:50118376-50118377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541342338 | chr8:50118377-50118378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182475704 | chr8:50118387-50118388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189190570 | chr8:50118430-50118431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376516849 | chr8:50118470-50118471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34912035 | chr8:50118485-50118486 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs373736351 | chr8:50118491-50118492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572708968 | chr8:50118507-50118508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7012516 | chr8:50118527-50118528 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs551715121 | chr8:50118563-50118564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576588363 | chr8:50118599-50118600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543918205 | chr8:50118607-50118608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35333021 | chr8:50118608-50118609 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs529275124 | chr8:50118621-50118622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541438517 | chr8:50118648-50118649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546231581 | chr8:50118666-50118667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560145071 | chr8:50118749-50118750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13268333 | chr8:50118775-50118776 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs13277014 | chr8:50118816-50118817 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs372543167 | chr8:50118831-50118832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13266232 | chr8:50118832-50118833 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs534120761 | chr8:50118859-50118860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549438183 | chr8:50118873-50118874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs13277298 | chr8:50118919-50118920 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs535044053 | chr8:50118921-50118922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546980660 | chr8:50118940-50118941 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs529896489 | chr8:50118967-50118968 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs565585369 | chr8:50118973-50118974 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs193082001 | chr8:50118977-50118978 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs540475274 | chr8:50119001-50119002 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs183846685 | chr8:50119013-50119014 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs560025768 | chr8:50119034-50119035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576544646 | chr8:50119056-50119057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368153731 | chr8:50119066-50119067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537661740 | chr8:50119078-50119079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75107718 | chr8:50119101-50119102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs35892058 | chr8:50119159-50119160 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs556547127 | chr8:50119232-50119233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144784761 | chr8:50119267-50119268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559679852 | chr8:50119278-50119279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577987173 | chr8:50119284-50119285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:50118200-50118400 | Enhancers | Pancreas | Pancrea |
2 | chr8:50118200-50118600 | Enhancers | GM12878-XiMat | blood |
3 | chr8:50118400-50119400 | Enhancers | Stomach Mucosa | stomach |
4 | chr8:50118400-50122200 | Weak transcription | Pancreas | Pancrea |
5 | chr8:50119400-50122200 | Weak transcription | Stomach Mucosa | stomach |
6 | chr8:50120600-50121400 | Enhancers | K562 | blood |
7 | chr8:50121400-50124800 | Weak transcription | K562 | blood |
8 | chr8:50122200-50122600 | ZNF genes & repeats | Pancreas | Pancrea |
9 | chr8:50122200-50123200 | Enhancers | Stomach Mucosa | stomach |
10 | chr8:50122400-50123200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr8:50122400-50123800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr8:50122800-50123600 | Enhancers | HUES64 Cell Line | embryonic stem cell |